Clinical Trial Update: Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is comparing tofacitinib and methotrexate for Takayasu arteritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Takayasu Arteritis | Phase 4 | Status: RECRUITING